Results for: drugmaker+novartis+ag

Pfizer 1Q profit up, but drugmaker cuts outlook

Novartis, Pfizer seek US approval of meningitis vaccines

Indian court to rule on generic drug industry

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Exclusive: Bayer, Novartis, others eye Merck's consumer health unit -...

Swiss vote on bosses' pay could hit offshore firms

Drugmakers, Interpol ramp up fight against fakes

India invites U.S. to discuss IP, market access issues

Novartis and Google to develop 'smart' contact lens

Novartis and Google to develop 'smart' contact lens

Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Swiss voters approve tough limits on bosses' pay

Valeant raises cash-stock offer for Allergan

Pfizer pulls plug on push to buy AstraZeneca

Merck Q4 net drops 14 pct. on generic competition

Novartis Q4 net profit rebounds to $2.1 billion

India's rejection of drug patent could reverberate

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

Drug maker Novartis loses India patent battle

A bitter pill as China crackdowns squeeze pharma margins

Eli Lilly says 'deeply concerned' by bribery allegations in China

Novartis lung cancer drug gets key FDA designation

Big Pharma pushes for U.S. action against India over patent worries

Tokyo prosecutors raid Novartis Japan unit over clinical data probe

Investor pressure pushing drugmaker M&A deals

US emergency labs ready to work on Ebola drugs if asked

Novartis Advances Most in Three Years on Heart-Failure Study

India's top court to deliver Novartis judgment

India's Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in...

GSK executive caught off-guard by China graft charges - sources

Bayer wins Merck &amp Co's $14 billion consumer unit auction

Drugmaker Novartis to eke out more cost savings to lift margins

Novartis loses new bid to dismiss U.S. lawsuit over kickbacks

Swiss mull creation of world's top minimum wage

Eli Lilly says 'deeply concerned' by bribery allegations in China

Novartis reshapes business with GSK, Lilly deals

India rejects Bayer plea against cheap cancer drug

Ahead of the Bell: Biogen shares keep climbing

Novartis advances most in five months on heart-failure study